A detailed history of Credit Agricole S A transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Credit Agricole S A holds 87,000 shares of GLSI stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
87,000
Previous 87,000 -0.0%
Holding current value
$1.06 Million
Previous $1.5 Million 16.72%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$12.07 - $19.04 $1.05 Million - $1.66 Million
87,000 New
87,000 $1.5 Million

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $157M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.